Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Research Design »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Research < Research Design < Research Report  Facettes :

List of bibliographic references indexed by Research Design

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000093 (2021) Derek Shyr [États-Unis] ; Yu Shyr [États-Unis]The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic.
000223 (2021) Jessica M. Franklin [États-Unis] ; Kueiyu Joshua Lin [États-Unis] ; Nicolle M. Gatto [États-Unis] ; Jeremy A. Rassen [États-Unis] ; Robert J. Glynn [États-Unis] ; Sebastian Schneeweiss [États-Unis]Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.
000253 (2021) Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran]Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
000338 (2021) Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni]Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000478 (2021) Hardeep Kaur [Inde] ; Phulen Sarma [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Subodh Kumar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
000521 (2021) Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada]Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000919 (2020) Mariacarla Gadebusch Bondio [Allemagne] ; Maria Marloth [Allemagne][The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].
000926 (2020) L. Boyer [France] ; P. Auquier [France] ; G. Fond [France][Real-life data and Covid-19: The third avenue of reseach].
000D33 (2020) Mahir Fidahic [Bosnie-Herzégovine] ; Danijela Nujic [Croatie] ; Renata Runjic [Croatie] ; Marta Civljak [Croatie] ; Filipa Markotic [Croatie] ; Zvjezdana Lovric Makaric [Croatie] ; Livia Puljak [Croatie]Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.
000D44 (2020) Julian D. Machiels [Pays-Bas] ; Chantal P. Bleeker-Rovers [Pays-Bas] ; Rob Ter Heine [Pays-Bas] ; Janette Rahamat-Langendoen [Pays-Bas] ; Quirijn De Mast [Pays-Bas] ; Jaap Ten Oever [Pays-Bas] ; Teun Bousema [Pays-Bas] ; Reinout Van Crevel [Pays-Bas] ; Heiman Fl Wertheim [Pays-Bas]Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
000E86 (2020) Javed Akram [Pakistan] ; Shehnoor Azhar [Pakistan] ; Muhammad Shahzad [Pakistan] ; Waqas Latif [Pakistan] ; Khalid Saeed Khan [Espagne]Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
000F27 (2020) Magnus Nakrem Lyngbakken [Norvège] ; Jan-Erik Berdal [Norvège] ; Arne Eskesen [Norvège] ; Dag Kvale [Norvège] ; Inge Christoffer Olsen [Norvège] ; Anbj Rg Rangberg [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Torbj Rn Omland [Norvège] ; Helge R Sj [Norvège] ; Olav Dalgard [Norvège]Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
001354 (2020) Yan Liu [République populaire de Chine] ; Xiaoxu Fu ; Chunguang XieEfficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
001467 (2020) Richard C. Becker [États-Unis]Covid-19 treatment update: follow the scientific evidence.
001617 (2020) Robin E. Ferner [Royaume-Uni] ; Jeffrey K. Aronson [Royaume-Uni]Chloroquine and hydroxychloroquine in covid-19.
001629 (2020) Arunmozhimaran Elavarasi [Inde] ; Manya Prasad [Inde] ; Tulika Seth [Inde] ; Ranjit Kumar Sahoo [Inde] ; Karan Madan [Inde] ; Neeraj Nischal [Inde] ; Manish Soneja [Inde] ; Atul Sharma [Inde] ; Subir Kumar Maulik [Inde] ; Shalimar [Inde] ; Pramod Garg [Inde]Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
001715 (2020) Thomas P. Lodise [États-Unis] ; Michael J. Rybak [États-Unis]COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.
001784 (2020) Paul Elias Alexander [Canada] ; Victoria Borg Debono [Canada] ; Manoj J. Mammen [États-Unis] ; Alfonso Iorio [Canada] ; Komal Aryal [Canada] ; Dianna Deng [Canada] ; Eva Brocard [France] ; Waleed Alhazzani [Canada]COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine.
001821 (2020) Bin Wang [République populaire de Chine] ; Junkai Lai [République populaire de Chine] ; Xiaoyan Yan [République populaire de Chine] ; Feifei Jin [République populaire de Chine] ; Bin Yi [République populaire de Chine] ; Caixia An [République populaire de Chine] ; Yuanxiao Li [République populaire de Chine] ; Chen Yao [République populaire de Chine]COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.
001859 (2020) Eric J. Rubin ; Lindsey R. Baden ; Stephen MorrisseyAudio Interview: Studying Potential Covid-19 Therapies.
001903 (2020) Gao Song ; Meng Qun Cheng ; Xian Wen Wei [République populaire de Chine]Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Research Design" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Research Design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Research Design
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021